-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Abbott Laboratories quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Abbott Laboratories Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $305M, a 16.9% increase year-over-year.
- Abbott Laboratories Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $952M, a 14.6% decline year-over-year.
- Abbott Laboratories annual Income Tax Expense (Benefit) for 2023 was $941M, a 31.5% decline from 2022.
- Abbott Laboratories annual Income Tax Expense (Benefit) for 2022 was $1.37B, a 20.4% increase from 2021.
- Abbott Laboratories annual Income Tax Expense (Benefit) for 2021 was $1.14B, a 129% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)